Literature DB >> 7759859

Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.

Y Ando1, W Wajjwalku, N Niimi, K Hiromatsu, T Morishima, Y Yoshikai.   

Abstract

We found that milk from II TES mice contained two species of exogenous mouse mammary tumor viruses (MMTV). Sequence analysis of the open reading frame (ORF) in the MMTV 3' long terminal repeat indicated that the two MMTV, MMTV (II TES2) and MMTV (II TES14), encode superantigens specific for V beta 2+ T cells and V beta 14+ T cells, respectively. In an experiment of subcutaneous injection of II TES milk, both T cells bearing TCR V beta 2 and V beta 14 proliferated vigorously in the draining lymph node from BALB/c mice (H-2d I-E+), whereas only V beta 14+ T cells showed significant proliferation in C57BL/6 mouse (B6 H-2b I-E-) lymph nodes. These findings indicated that the superantigen encoded by MMTV (II TES2) required MHC class II I-E molecules exclusively for Ag presentation, but MMTV (II TES14) stimulated V beta 14+ T cells even in the absence of I-E molecules. Semiquantitative analysis of MMTV proviruses using PCR revealed that B6 mice were not infected with MMTV (II TES2) by injection of this MMTV alone. However, injection of II TES milk containing both MMTV (II TES14) and MMTV (II TES2) induced infection of B6 mice with MMTV (II TES2) besides MMTV (II TES14), in spite of no expansion of V beta 2+ T cells in this mouse strain. These results suggested that I-E-negative mice were concomitantly infected with MMTV (II TES2) with the help of I-E independent T cell activation mediated by MMTV (II TES14).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759859

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Nucleotide sequences of env and 3'LTROrf genes of endogenous mouse mammary tumor viruses encoding superantigen specific for TcrVbeta2.

Authors:  N Nakamura; W Wajjwalku; H Nishimura; H Okubo; N Niimi; Y Ando; Y Yoshikai
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.

Authors:  T J Wrona; M Lozano; A A Binhazim; J P Dudley
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells.

Authors:  M Umemura; W Wajjwalku; N Upragarin; T Liu; H Nishimura; T Matsuguchi; Y Nishiyama; G M Wilson; Y Yoshikai
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 5.  Intestinal Immune System and Amplification of Mouse Mammary Tumor Virus.

Authors:  Lankai Chen; Xipeng Zhang; Guisheng Liu; Shuo Chen; Minying Zheng; Siwei Zhu; Shiwu Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.